1. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.
    Maryam Tahmasebi Birgani et al, 2017, Int J Mol Sci CrossRef
  2. Small Molecules for Neural Stem Cell Induction
    Donghui Liu et al, 2018, Stem Cells and Development CrossRef
  3. miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition
    Chunmei Guo et al, 2018, Sci Rep CrossRef
  4. SETDB1-mediated FosB regulation via ERK2 is associated with an increase in cell invasiveness during anticancer drug treatment of A549 human lung cancer cells
    Han-Heom Na et al, 2018, Biochemical and Biophysical Research Communications CrossRef
  5. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4-MMP1 axis
    Eunjeong Kim et al, 2018, Hepatology CrossRef
  6. Role of MAPK/MNK1 signaling in virus replication
    Ram Kumar et al, 2018, Virus Research CrossRef
  7. Biliverdin reductase and bilirubin in hepatic disease
    Lauren Weaver et al, 2018, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
  8. Extracellular matrix collagen I promotes the tumor progression of residual hepatocellular carcinoma after heat treatment
    Rui Zhang et al, 2018, BMC Cancer CrossRef
  9. Regions of multistationarity in cascades of Goldbeter–Koshland loops
    Magalí Giaroli et al, 2018, J. Math. Biol. CrossRef
  10. Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs
    Manjula Vinayak, 2018, Nutrition and Cancer CrossRef
  11. A review of computational approaches for analysis of hepatitis C virus-mediated liver diseases
    Sumanta Ray et al, 2017 CrossRef
  12. null
    Venice Wing Tung Ho et al, 2019 CrossRef
  13. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro
    Wei-Ting Chen et al, 2019, IJMS CrossRef
  14. Myelodysplastic syndrome related alterations of MAPK signaling in the of bone marrow of experimental mice including stem/progenitor compartment
    Suchismita Daw et al, 2019, Acta Histochemica CrossRef
  15. Urgent Necessity for Standardized and Evidence Based Plant Immunomodulators (Such As Rice Bran Arabinoxylan Concentrate/MGN-3) for the Tumor Research
    Tibor Hajto, 2018, IJCAM CrossRef
  16. Cylindrospermopsin induces cellular stress and activation of ERK1/2 and p38 MAPK pathways in adult human liver stem cells
    Jan Raška et al, 2019, Chemosphere CrossRef
  17. Ras-ERK1/2 signalling promotes the development of osteosarcoma through regulation of H4K12ac through HAT1
    Jingzhe Zhang et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  18. The environmental obesogen bisphenol A increases macrophage self-renewal
    Grace Ampem et al, 2019, Cell Tissue Res CrossRef
  19. Mathematical Modeling Reveals That the Administration of EGF Can Promote the Elimination of Lymph Node Metastases by PD-1/PD-L1 Blockade
    Mohamed Amine Benchaib et al, 2019, Front. Bioeng. Biotechnol. CrossRef
  20. Chemical inhibition reveals differential requirements of signaling pathways in krasV12- and Myc-induced liver tumors in transgenic zebrafish
    Chuan Yan et al, 2017, Sci Rep CrossRef
  21. Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
    Elodie Villa et al, 2019, Cancers CrossRef
  22. Block of NF-kB signaling accelerates MYC-driven hepatocellular carcinogenesis and modifies the tumor phenotype towards combined hepatocellular cholangiocarcinoma
    Jiajia He et al, 2019, Cancer Letters CrossRef
  23. AKT and ERK dual inhibitors: The way forward?
    Zhe Cao et al, 2019, Cancer Lett CrossRef
  24. A benchmark dataset for analyzing and visualizing the dynamic epiproteome
    Sandeep Kaur et al, 2019, Data in Brief CrossRef
  25. null
    Aniket Kumar Bansal et al, 2019 CrossRef
  26. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway
    Jin Sun et al, 2019, J Cell Biochem CrossRef
  27. Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma
    Cristian Scheau et al, 2019, Molecules CrossRef
  28. RAS in pancreatic cancer
    Simone Lanfredini et al, 2019, Biochm. Soc. Trans. CrossRef
  29. Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression
    Maryam Ranjpour et al, 2019, ACAMC CrossRef
  30. Novel Function of Bluetongue Virus NS3 Protein in Regulation of the MAPK/ERK Signaling Pathway
    Cindy Kundlacz et al, 2019, J Virol CrossRef
  31. Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p
    Zhiqin Li et al, 2019, Cancer Cell Int CrossRef
  32. JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
    Haiming Chen et al, 2019, Br J Haematol CrossRef
  33. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo
    Xiaoni Liu et al, 2017 CrossRef
  34. Components of the hepatocellular carcinoma microenvironment and their role in tumor progression
    M. V. Novikova et al, 2017, Biochemistry Moscow CrossRef
  35. Lectin BS-I inhibits cell migration and invasionviaAKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma
    Qiang Jian et al, 2018, J. Cell. Mol. Med. CrossRef
  36. Mutation-Specific Mechanisms of Hyperactivation of Noonan Syndrome SOS Molecules Detected with Single-molecule Imaging in Living Cells
    Yuki Nakamura et al, 2017, Sci Rep CrossRef
  37. Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’
    Cyriac Abby Philips et al, 2019 CrossRef
  38. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
    Farzad Rahmani et al, 2019, J Cell Physiol CrossRef
  39. Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
    Saharnaz Sarlak et al, 2019, Seminars in Cell & Developmental Biology CrossRef
  40. Ursonic acid exerts inhibitory effects on matrix metalloproteinases via ERK signaling pathway
    Juhyeon Son et al, 2019, Chemico-Biological Interactions CrossRef
  41. The multi-faceted functioning portrait of LRF/ZBTB7A
    Caterina Constantinou et al, 2019, Hum Genomics CrossRef
  42. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
    Nancy S Younis et al, 2019, Sci Rep CrossRef
  43. Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met
    Mohamed Y. Zaky et al, 2019, Archives of Biochemistry and Biophysics CrossRef
  44. Activation of extracellular signal‐regulated kinase is associated with hepatocellular carcinoma with aggressive phenotypes
    Takuya Minagawa et al, 2019, Hepatol Res CrossRef
  45. Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
    Sandeep Kumar et al, 2020, Pharmaceuticals CrossRef
  46. Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells
    Linxia Xiao et al, 2020, PRA CrossRef
  47. null
    Filipa Lopes-Coelho et al, 2020 CrossRef
  48. Degradation of HOX Transcript Antisense RNA Provoked Apoptosis and Necrosis in Human Ovarian Cancer Cells
    Mahsa Sabet et al, 2020, Indian J Gynecol Oncolog CrossRef
  49. Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells
    Jung Hwan Yoon et al, 2020, Gastric Cancer CrossRef
  50. Loss of c‐Jun N‐terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
    Francisco Javier Cubero et al, 2020, Hepatol Commun CrossRef
  51. Three‐dimensional culture models to study drug resistance in breast cancer
    Madeline F. Fisher et al, 2020, Biotechnology and Bioengineering CrossRef
  52. An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics.
    Youssef W Naguib et al, 2021, Drug Deliv Transl Res CrossRef
  53. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
    Yanling Liu et al, 2020, Nanoscale Res Lett CrossRef
  54. β‐Arrestin1 is involved in hepatocellular carcinoma metastasis via extracellular signal‐regulated kinase‐mediated epithelial–mesenchymal transition
    Xuan Xu et al, 2020, Journal of Gastroenterology and Hepatology CrossRef
  55. COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma.
    Yu-De Chu et al, 2020, Cancers (Basel) CrossRef
  56. Engineering Cell‐Derived Matrices: From 3D Models to Advanced Personalized Therapies
    Gerard Rubi‐Sans et al, 2020, Adv. Funct. Mater. CrossRef
  57. SIRT6 regulates the proliferation and apoptosis of hepatocellular carcinoma via the ERK1/2 signaling pathway
    Cuisheng Zhang et al, 2019, Mol Med Report CrossRef
  58. Anti‑cancer effects of a novel Pan‑RAF inhibitor in a hepatocellular carcinoma cell line
    Wei Wang et al, 2018, Mol Med Report CrossRef
  59. Valosin‑containing protein promotes metastasis of osteosarcoma through autophagy induction and anoikis inhibition via the ERK/NF‑κβ/beclin‑1 signaling pathway
    Xin Long et al, 2019, Oncol Lett CrossRef
  60. Bifidobacterium breve UCC2003 Induces a Distinct Global Transcriptomic Program in Neonatal Murine Intestinal Epithelial Cells
    Raymond Kiu et al, 2020, iScience CrossRef
  61. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance
    Behnam Alipoor et al, 2020, Mol Biol Rep CrossRef
  62. Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment
    Juliana F. Vilachã et al, 2020, Crystals CrossRef
  63. Structure-Dependent Effects of Phthalates on Intercellular and Intracellular Communication in Liver Oval Cells
    Lucie Čtveráčková et al, 2020, IJMS CrossRef
  64. Non-hormonal mediators of uterine fibroid growth
    Esra Cetin et al, 2020 CrossRef
  65. Sinonasal Inverted Papilloma: A Narrative Review
    Ila B. Upadhya et al, 2020, Indian J Otolaryngol Head Neck Surg CrossRef
  66. miR-124-3p Suppresses the Invasiveness and Metastasis of Hepatocarcinoma Cells via Targeting CRKL
    Abbasi Majid et al, 2020, Front. Mol. Biosci. CrossRef
  67. Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges
    Emanuele Rinninella et al, 2020, Nutrients CrossRef
  68. Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells
    Min Hee Yang et al, 2020, IJMS CrossRef
  69. Afadin (AF6) in cancer progression: A multidomain scaffold protein with complex and contradictory roles
    Jennifer Huxham et al, 2020, BioEssays CrossRef
  70. Signal Transduction in Hepatocellular Carcinoma: Insights from Zebrafish
    Madan Mohan Udaya Kumar et al, 2020, Proc. Singapore Natl. Acad. Sci. CrossRef
  71. LDL, HDL and endocrine-related cancer: from pathogenic mechanisms to therapies
    Giovanna Revilla et al, 2020, Seminars in Cancer Biology CrossRef
  72. REGULATION OF CELLULAR ANABOLISM BY MTOR: OR HOW I LEARNED TO STOP WORRYING AND LOVE TRANSLATION
    J. William Deaver et al, 2020, Sports Medicine and Health Science CrossRef
  73. Autosomal dominant polycystic kidney disease and pioglitazone for its therapy: a comprehensive review with an emphasis on the molecular pathogenesis and pharmacological aspects
    Aryendu Kumar Saini et al, 2020, Mol Med CrossRef
  74. A Rab escort protein regulates the MAPK pathway that controls filamentous growth in yeast
    Sheida Jamalzadeh et al, 2020, Sci Rep CrossRef
  75. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation
    Wei-Chung Hsu et al, 2020, Phytomedicine CrossRef
  76. Effect of Periodontitis and Scaling and Root Planing on Risk of Pharyngeal Cancer: A Nested Case—Control Study
    Ping-Ju Chen et al, 2020, IJERPH CrossRef
  77. Three new 3-formyl-2-arylbenzofurans from Itea yunnanensis and their anti-hepatocellular carcinoma effects
    Tian-Qiong Lang et al, 2020, Natural Product Research CrossRef
  78. Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents
    Asbiel Hasbum et al, 2021, Future Medicinal Chemistry CrossRef
  79. Increase in PPARγ inhibitory phosphorylation by Fetuin—A through the activation of Ras-MEK-ERK pathway causes insulin resistance
    Snehasis Das et al, 2021, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  80. The differential expression of Promyelocytic Leukemia (PML) and retinoblastoma (RB1) genes in breast cancer
    Banashree Bondhopadhyay et al, 2021, Meta Gene CrossRef
  81. The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy
    Gianni Frascotti et al, 2021, Cancers CrossRef
  82. A Network-Based Method for Mechanistic Investigation and Neuroprotective Effect on treatment of Tanshinone Ⅰ Against Ischemic Stroke in Mouse
    Jiajia Liu et al, 2021, Journal of Ethnopharmacology CrossRef
  83. Comparative anticancer activities of Ficus carica and Ficus salicifolia latex in MDA-MB-231 cells
    Fatma Mousa AlGhalban et al, 2021, Saudi Journal of Biological Sciences CrossRef
  84. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer
    Agata Binienda et al, 2020, ACAMC CrossRef
  85. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis
    Hang Xing et al, 2021, J Mol Neurosci CrossRef
  86. Suppression of Heterogeneous Nuclear Ribonucleoprotein C Inhibit Hepatocellular Carcinoma Proliferation, Migration, and Invasion via Ras/MAPK Signaling Pathway
    Jiejun Hu et al, 2021, Front. Oncol. CrossRef
  87. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
    Fatemeh Khojasteh Poor et al, 2021, BD CrossRef
  88. Biological Therapy with Complementary and Alternative Medicine in Innocuous Integrative Oncology: A Case of Cervical Cancer
    Elvin Peter Chizenga et al, 2021, Pharmaceutics CrossRef
  89. Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice
    Noreen McBrearty et al, 2021, Neoplasia CrossRef
  90. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma
    Gundula Streubel et al, 2021, Sci Rep CrossRef
  91. Angiogenic Properties of Placenta-Derived Extracellular Vesicles in Normal Pregnancy and in Preeclampsia
    Natalia Gebara et al, 2021, IJMS CrossRef
  92. LncRNA H19 Upregulation Participates in the Response of Glioma Cells to Radiation
    Yanbei Kuang et al, 2021, BioMed Research International CrossRef
  93. Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition
    Malgorzata Jozkowiak et al, 2021, IJMS CrossRef
  94. null
    Syed Zameer Hussain et al, 2021 CrossRef
  95. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
    Hyuk Moon et al, 2021, Cancers CrossRef
  96. Seaweed Components as Potential Modulators of the Gut Microbiota
    Emer Shannon et al, 2021, Marine Drugs CrossRef
  97. null
    Diamantis I. Tsilimigras et al, 2020 CrossRef
  98. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
    Pin Zhao et al, 2021, Front. Oncol. CrossRef
  99. Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAFV600E melanoma-bearing mice
    Aml I. Mekkawy et al, 2021, International Journal of Pharmaceutics CrossRef
  100. Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma
    Nobuhiko Asakura et al, 2021, IJMS CrossRef
  101. Albendazole-loaded cubosomes interrupt the ERK1/2-HIF-1α-p300/CREB axis in mice intoxicated with diethylnitrosamine: A new paradigm in drug repurposing for the inhibition of hepatocellular carcinoma progression
    Sameh Saber et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  102. Low concentrations of 4-ABP promote liver carcinogenesis in human liver cells and a zebrafish model
    Heng-Dao Lin et al, 2021, Journal of Hazardous Materials CrossRef
  103. Perspective: The Mechanobiology of Hepatocellular Carcinoma
    Abigail E. Loneker et al, 2021, Cancers CrossRef
  104. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma
    Xu Chao et al, 2021, BioMed Research International CrossRef
  105. LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling
    Qingchun Lu et al, 2021, ncRNA CrossRef
  106. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update
    Zahra Torki et al, 2021, Cancer Chemother Pharmacol CrossRef
  107. YRDC Mediates the Resistance of Lenvatinib in Hepatocarcinoma Cells via Modulating the Translation of KRAS
    Jun Guo et al, 2021, Front. Pharmacol. CrossRef
  108. The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles
    Kanawat Wiwatchaitawee et al, 2021, Drug Deliv. and Transl. Res. CrossRef
  109. Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
    Martha Dillon et al, 2021, Cancers CrossRef
  110. Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment
    Verica Vasic et al, 2021, Genes CrossRef
  111. The Biomimetic Extracellular Matrix: a Therapeutic Tool for Breast Cancer Research
    Marta Tamayo-Angorrilla et al, 2021, Translational Research CrossRef
  112. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics
    Jaishree Pandian et al, 2022, Experimental Cell Research CrossRef
  113. The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics
    Elham Zeinalzadeh et al, 2021, Front. Genet. CrossRef
  114. Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide.
    Yousra M El-Far et al, 2022, Redox Rep CrossRef
  115. Fenbendazole Suppresses Growth and Induces Apoptosis of Actively Growing H4IIE Hepatocellular Carcinoma Cells via p21-Mediated Cell-Cycle Arrest
    Deokbae Park, 2022, Biological & Pharmaceutical Bulletin CrossRef
  116. Semisynthesis and biological evaluation of (+)-sclerotiorin derivatives as antitumor agents for the treatment of hepatocellular carcinoma
    Yang Hai et al, 2022, European Journal of Medicinal Chemistry CrossRef
  117. null
    Gayatri Gouda et al, 2022 CrossRef
  118. Biomarker LEPRE1 induces pelitinib-specific drug responsiveness by regulating ABCG2 expression and tumor transition states in human leukemia and lung cancer
    A-Ram Lee et al, 2022, Sci Rep CrossRef
  119. Monocarboxylate Transporters Are Involved in Extracellular Matrix Remodelling in Pancreatic Ductal Adenocarcinoma
    Ayşe Ufuk et al, 2022, Cancers CrossRef
  120. Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
    Ying Zhang et al, 2022, npj Breast Cancer CrossRef
  121. Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based Synthetic Anticancer Drug Design by Crystallography
    Sisir Nandi et al, 2022, ACAMC CrossRef
  122. null
    Fayyaz Rasool et al, 2022 CrossRef
  123. Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action
    Abdul Waheed Khan et al, 2022, Cells CrossRef
  124. The roles of epidermal growth factor receptor in viral infections
    Kah Man Lai et al, 2022, Growth Factors CrossRef
  125. Antiangiogenic and apoptotic effects of benzyl caffeate on human umbilical vein endothelial cells (HUVECs) and chick embryo chorioallantoic membrane (CAM): In vitro and in vivo models
    Ho-Jeong Bang et al, 2022, Journal of Functional Foods CrossRef
  126. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers.
    Hong-Beom Park et al, 2022, Biochim Biophys Acta Rev Cancer CrossRef
  127. Targeting the effect of sofosbuvir on selective oncogenes expression level of hepatocellular carcinoma Ras/Raf/MEK/ERK pathway in Huh7 cell line
    Muhammad Atif et al, 2022, Saudi Journal of Biological Sciences CrossRef
  128. The regulation of shrimp metabolism by the white spot syndrome virus (WSSV)
    Ramya Kumar et al, 2022, Reviews in Aquaculture CrossRef
  129. Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
    Julia Koch-Heier et al, 2022, Front. Pharmacol. CrossRef
  130. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma
    Tao Wang et al, 2021, CMC CrossRef
  131. SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19?
    Morteza Ghasemnejad-Berenji et al, 2021, Pharmacology CrossRef
  132. GANT61/BI-847325 combination: a new hope in lung cancer treatment
    Abdel Halim M. El-Kishky et al, 2022, Med Oncol CrossRef
  133. The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
    Naoshad Muhammad et al, 2022, Cells CrossRef
  134. Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances
    Hao Qin et al, 2022, Front. Oncol. CrossRef
  135. Metformin Enhances the Anti-Cancer Efficacy of Sorafenib via Suppressing MAPK/ERK/Stat3 Axis in Hepatocellular Carcinoma
    Sumit Siddharth et al, 2022, IJMS CrossRef
  136. Nutraceuticals Derived from Dietary Spices as Candidate Molecules in Targeting Glioma Signaling Pathways
    Vinitha Rani et al, 2022, Rev. Bras. Farmacogn. CrossRef
  137. A Comprehensive Review on the Therapeutic Versatility of Imidazo [2,1-b]thiazoles
    Mohd Adil Shareef et al, 2020, CMC CrossRef
  138. Potential Therapeutic Strategies to Combat HCC
    Sidra Altaf et al, 2022, CMP CrossRef
  139. Computational analysis of natural product B-Raf inhibitors
    Sumiran Chettri et al, 2022, Journal of Molecular Graphics and Modelling CrossRef
  140. NEIL3 promotes hepatoma epithelial–mesenchymal transition by activating the BRAF / MEK / ERK / TWIST signaling pathway
    Hui‐Huang Lai et al, 2022, The Journal of Pathology CrossRef
  141. Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
    Xueli Tian et al, 2022, Mol Cancer CrossRef
  142. Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms
    Ruchi Bhuyan et al, 2022, Biomedicines CrossRef
  143. Exploring CDKs, Ras-ERK, and PI3K-Aktin Abnormal Signaling and Cancer
    Sisir Nandi et al, 2022, J. Can. Res. Updates CrossRef
  144. Thymoquinone Suppresses Angiogenesis in DEN-Induced Hepatocellular Carcinoma by Targeting miR-1-3p
    Samer A. Tadros et al, 2022, IJMS CrossRef
  145. Exploration of Chemopreventive Potential of Linalool in Targeting Lung Cancer Biomarkers
    Jyoti Singh et al, 2022, EMIDDT CrossRef
  146. MAP kinase phosphatase MKP-1 regulates p-ERK1/2 signaling pathway with fluoride treatment.
    Lin Zhao et al, 2021, Biochem Biophys Res Commun CrossRef
  147. Jia-Wei-Si-Miao-Yong-An Fang stimulates the healing of acute radiation-induced cutaneous wounds through MAPK/ERK pathway
    Yin Wang et al, 2023, Journal of Ethnopharmacology CrossRef
  148. Computational assessment of chemicals from Morinda citrifolia as potential inhibitors of B-Raf kinase in hepatocellular carcinoma treatment
    Chinenye Jane Ugwah-Oguejiofor et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef